Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000790772 | SCV000225262 | pathogenic | not provided | 2013-10-18 | criteria provided, single submitter | clinical testing | |
Dunham Lab, |
RCV000066233 | SCV002599389 | pathogenic | Anemia, nonspherocytic hemolytic, due to G6PD deficiency | 2022-08-12 | criteria provided, single submitter | curation | Variant found in unrelated hemizygotes with deficiency and jaundice, acute anemia, and CNSHA (PS4_M, PP4). In one family, variant segregates with deficiency (PP1). In another, hemizygote with CNSHA does not have variant, so assumed de novo (PM6). Decreased activity in red blood cells of hemizygotes (1-5%) (PS3). Not found in gnomAD (PM2). Reported as pathogenic by Eurofins (PP5). Post_P 0.999 (odds of pathogenicity 13661, Prior_P 0.1). |
Fulgent Genetics, |
RCV002496322 | SCV002813982 | likely pathogenic | Malaria, susceptibility to; Anemia, nonspherocytic hemolytic, due to G6PD deficiency | 2022-05-03 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000011091 | SCV000031318 | other | G6PD SANTIAGO DE CUBA | 1989-07-25 | no assertion criteria provided | literature only | |
OMIM | RCV000066233 | SCV005374536 | pathogenic | Anemia, nonspherocytic hemolytic, due to G6PD deficiency | 1989-07-25 | no assertion criteria provided | literature only |